Meeting
2021 ASCO Annual Meeting
High prevalence of actionable germline variants in unselected endometrial cancer (EC) patients.
Authors
Monica Levine
The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH
Monica Levine , Rachel Pearlman , Heather Hampel , Casey Cosgrove , David E. Cohn , Alexis Chassen , Adrian Suarez , Steven E. Waggoner , Caroline Billingsley , Kimberly Erin Resnick , Steve Andrews , Sareena Singh , Eric Jenison , Aine Emma Clements , Robert Neff , Paul J. Goodfellow
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Clinical Trial Registration Number
NCT03460483
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5577)
DOI
10.1200/JCO.2021.39.15_suppl.5577
Abstract #
5577
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Retrospective analysis of non-BRCA gene pathogenicity variation in Chinese patients with ovarian cancer.
First Author: Li yuan Guo
Poster
2023 ASCO Annual Meeting
Investigation of cancer predisposition in Fanconi anemia heterozygotes: A DiscovEHR cohort population study.
First Author: Joseph Deng
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian
Poster
2018 ASCO Annual Meeting
Feasibility of perioperative multi-gene panel testing (MGPT) in cancer patients eligible for hereditary genetic evaluation (GE): The PROTECT pilot.
First Author: Michael J. Hall